Abstract:The novel lysergamide 1‐(furan‐2‐carbonyl)‐LSD (1F‐LSD) was analytically characterized. 1F‐LSD showed LSD‐like activity in vivo similar to 1‐(thiophene‐2‐carbonyl)‐LSD (1T‐LSD) used for comparison. Administration studies in mice and LC–MS analysis revealed that 1F‐LSD served as a prodrug. Receptor binding data for 1F‐LSD at twenty‐two monoaminergic sites were also included. The classical psychedelic drug (+)‐lysergic acid diethylamide (LSD) continues to attract considerable multidisciplinary interest, and over the last eight decades, many derivatives and analogs of LSD have been synthesized. One site on the ergoline scaffold of LSD that has been frequently modified is the N1‐position, with the N1‐acylated LSD derivative 1‐acetyl‐LSD (1A‐LSD, ALD‐52) being one of the earliest examples. In more recent years, several other alkylcarbonyl‐ and cycloalkylcarbonyl‐substituted LSD derivatives have been evaluated, including several distributed as research chemicals. Although N1‐substitution is detrimental for the activity of LSD at the 5‐HT2A receptor (the primary site of action of psychedelic drugs), N1‐acylated LSD derivatives are rapidly hydrolyzed in vivo and are believed to act as prodrugs for LSD. Recently, 1‐(thiophene‐2‐carbonyl)‐LSD (1T‐LSD, SYN‐L‐021) was detected as a new recreational drug, signaling a move towards N1‐acyl groups with an aromatic character. The present study was conducted to investigate the analytical profile and pharmacology of 1‐(2‐furoyl)‐lysergic acid diethylamide (1F‐LSD, SYN‐L‐005), a novel analog of 1T‐LSD. The binding of 1F‐LSD to the 5‐HT2A receptor and other monoamine sites was assessed using radioligand binding. Furthermore, the in vivo activities of 1F‐LSD and 1T‐LSD were assessed in C57BL/6 J mice by comparing their biotransformation to LSD and effects on the head‐twitch response (HTR), a 5‐HT2A‐mediated behavior. Both 1F‐LSD and 1T‐LSD induced the HTR in mice and were hydrolyzed to LSD after in vivo administration, indicating that both substances exhibit LSD‐like properties and may serve as prodrugs for LSD.

1-Aminomethylbenzocycloalkanes: conformationally restricted hallucinogenic phenethylamine analogues as functionally selective 5-HT2A receptor agonists

Synthesis And Characterization Of 5-Hydroxy-2-(2-Phenylethyl)Chromone (5-Hpec) And Its Analogues As Non-Nitrogenous 5-Ht2b Ligands

Investigation of the 2,5-Dimethoxy Motif in Phenethylamine Serotonin 2A Receptor Agonists

Effect of Bulky N -Dibenzofuranylmethyl Substitution on the 5-HT 2 Receptor Affinity and Efficacy of a Psychedelic Phenethylamine

Structure-based discovery of nonhallucinogenic psychedelic analogs

Use of the head-twitch response to investigate the structure-activity relationships of 4-thio-substituted 2,5-dimethoxyphenylalkylamines

Pharmacological characterization of the LSD analog N-ethyl-N-cyclopropyl lysergamide (ECPLA)

Comparison of the behavioral effects of mescaline analogs using the head twitch response in mice

Analytical and Pharmacological Characterization of 1‐(Furan‐2‐Carbonyl)‐LSD (1F‐LSD) and Comparison With 1‐(Thiophene‐2‐Carbonyl)‐LSD (1T‐LSD)

Dopamine/serotonin receptor ligands. Part IV [1]: synthesis and pharmacology of novel 3-benzazecines and 3-benzazonines as potential 5-HT2A and dopamine receptor ligands

Synthesis and Structure-Activity Relationships of 2,5-Dimethoxy-4-Substituted Phenethylamines and the Discovery of CYB210010: A Potent, Orally Bioavailable and Long-Acting Serotonin 5-HT 2 Receptor Agonist

Discovery and Structure-Activity Relationships of 2,5-Dimethoxyphenylpiperidines as Selective Serotonin 5-HT 2A Receptor Agonists

Hallucinogens Recruit Specific Cortical 5-HT2A Receptor-Mediated Signaling Pathways to Affect Behavior

Structural Insights into Tryptamine Psychedelics: the Role of Hydroxyl Indole Ring Site in 5-HT2A Receptor Activation and Psychedelic-like Activity

The selective 5-HT receptor agonist LPH-5 induces persistent and robust antidepressant-like effects in rodents

Synthesis and Pharmacological Characterization of 4-Substituted-2-aminobicyclo[3.1.0]hexane-2,6-dicarboxylates: Identification of New Potent and Selective Metabotropic Glutamate 2/3 Receptor Agonists.

Serotonin 2A Receptor (5-HT 2A R) Agonists: Psychedelics and Non-Hallucinogenic Analogues as Emerging Antidepressants

Synthesis and pharmacological characterization of conformationally restricted 2-amino-Adipic acid analogs and carboxycyclopropyl glycines as selective metabotropic glutamate 2 receptor agonists

Evaluation of the Indazole Analogs of 5-MeO-DMT and Related Tryptamines as Serotonin Receptor 2 Agonists

Receptor Interaction Profiles of 4-Alkoxy-3,5-Dimethoxy-Phenethylamines (Mescaline Derivatives) and Related Amphetamines